ATT CEO Highlights BlueCollar Worker Shortage as AI Reshapes Economy Retail Spending Resilience Continues Amid Economic Uncertainty National Retail Federation Reports Telangana Cabinet Approves New Life Sciences Policy 202630 with RD Incentives London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance Charter Communications Agrees to Acquire Liberty Broadband at Enhanced Terms Jim Cramer Endorses The TJX Companies TJX as a Strong Investment Wells Fargo Q1 2026 Earnings Slight EPS Beat Amid Steady Operating Performance LTRN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Control as RD Pipeline Advances Alliant Energy LNT Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency and Rate Base Growth XMTR Q1 2026 Earnings EPS Beats Estimates by 1385 as Marketplace Momentum Continues JNJ Q1 2026 Earnings Narrow EPS Beat Signals Operational Resilience Amid Mixed Market Sentiment BTC Digital BTCT Surges 364 as Bullish Momentum Tests Key Resistance at 120 Sanofi Shares Slip Potential Support Test Ahead for SNY A Paradise Acquisition Corp Unit APADU Holds Steady at 100 Amid Neutral Trading Southern Company Preferred Stock SOJE Edges Higher Testing Key Resistance Seer Inc SEER Gains 45 as Biotech Stock Nears Key Resistance Level Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Changing Cybersecurity Demand Trends Balchem Q1 2026 Earnings EPS Misses Estimates Amid Modest Stock Gain Ciena Corporation CIEN Slides 215 as Bearish Pressure Intensifies Near Key Support Huron Consulting Group Q1 2026 Earnings EPS Surpasses Estimates by 58 Heartflow Inc HTFL Q1 2026 Earnings EPS Misses Estimates Amid Key Operational Developments Acacia Research Corporation ACTG Q1 2026 Earnings Significant EPS Miss Amidst Uncertain Revenue Landscape DVS Q4 2025 Earnings WiderthanExpected Loss Reflects Exploration Focus Leonardo DRS Inc DRS Q1 2026 Earnings EPS Beat Drives Modest Stock Gain TrueBlue Inc Q1 2026 Earnings EPS Surprises Above Estimates Despite Negative Earnings LEXX Q1 2026 Earnings Narrower Loss Surprises as Bioscience Firm Advances Drug Delivery Pipeline